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Tradit ional ly,research in diseases associated with a monoclonal compo-
nent is one of the scienti f ic interests on the Department of Internal
Medicine, University Hospital Groningen, The Netherlands. The study
reported in this thesis and performed in the Immunochemical Iaborarory, is
to be regarded as a continuation of this research-line.
The etiology of a monoclonal gammopathy is st i l l  an open quesrion.
Reported multiple occurrence of monoclonal components and other immu-
noglobulin abnormalities within families suggested the influence of geneti-
cally determined factors. In order to trace such factors Fesren srarted tn7970
a systematic study of family me'nbers of patients with myelomatosis, one of
the clinical entities associated with an M-componen t. In I97 4 in his rhesis
Festen reported on serum immunoglobulin levels in first-degree relatives of
patients with myelomatosis. The serum immunoglobulin levels being
regarded as a refiection of the genetically controlled magnitude of immune
responsiveness.
In the present thesis research has been focussed on twoaddit ionalgeneti-
cally determined factors, which could play a recognizable role in the onset of
monoclonal gammopathy. In an extension of the family study the influence
of a disturbance in the genetic control of the heterogeneity of an immune
response has been studied in three families with multiple occurrence of
M-components. The second factor studied in this thesis is the genetic control
of immunoglobulin structure. A patient with two M-components in his
serum was investigated in terms of the relat ionship in strucrure and cel lular
local izat ion of biosynthesis of both monoclonal proteins.
The complexity and the many aspects of the present study gave rise to a
detailed chapter 2. The structure of the immunoglobulin molecule is
reviewed. Special attention is payed on idiotypy because antisera raised
against idiotypic determinants of M-components form an important
experimental tool in this study. The genetic control of the immune response
is ample discussed. Data on the genetic conrrol of immunoglobulin srrucrure
are summarized in view of the experimenrs on double gammoparhy
(reported in chapter 4). The genetic conrrol of the magnirude of the immune
response is discussed in relation to the famiiy study which preceded the
present one. The genetic control of rhe heterogeneity of an immune
response is reviewed because the hypothesis tested in our part of the family
study is mainly based on these data (reported in chapter 3). B-cell
proliferative diseases are briefly mentioned in order to stress their close
relationship. Finally, a survey is given on the familial occurrence of
immunoglobulin abnormalities and on double gammopathy.
The experimental data are comprised in two chapters. In chapter 3 our
hypothesis that an inherited restriction in the number of available V-region
genes contributes to a genetic predisposition for monoclonal gammopathy is
tested. Results are shown and discussed of experiments performed with a
hemagglutination inhibition technique and with a radiobinding inhibition
assay. In chapter 4 results are described of a study on a patient with double
gammopathy. Idiotypic antisera, raised against the distinctive M-
componen ts  we re  app l i ed  i n  rad io immunoassays  and  i n
immunofluorescence studies of bone marrow smears.
In chapter 5 the experimental data from chapter 3 and 4are discussed with
regard to their contribution to the understanding of the genetics of the
immune response. Finally, a summary is given in English and Dutch,
followed bv a list of references.
